<html>
<head>PUBMED IDs for CCDC62</head>
<body bgcolor='#C5F0F2'><h1>CCDC62</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19126643/'>CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19165854/'>Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.</a> April 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22254151/'>The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.</a> January 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24312176/'>Genetic association study between STK39 and CCDC62/HIP1R and Parkinson's disease.</a> September 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25818163/'>The single nucleotide polymorphism Rs12817488 is associated with Parkinson's disease in the Chinese population.</a> April 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25818147/'>The Impact of Genetics on Physical Resilience and Successful Aging.</a> October 16  2015<br></body></html>
